Standard BioTools Inc. Fair Value, Liabilities Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31)
Standard BioTools Inc. (LAB) reported Fair Value, Liabilities Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-12.
Discontinued › Income Statement › Other Income
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInOtherIncome · last filed 2013-03-12
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $0.00.
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $0.00.
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $0.00.
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for the quarter ending 2012-03-31 was $0.00.
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for fiscal 2012 was $0.00.
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for fiscal 2011 was -$1.48M.
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for fiscal 2010 was -$445.00K.
- Standard BioTools Inc. fair value, liabilities measured on recurring basis, gain (loss) included in other income (deprecated 2013-01-31) for fiscal 2009 was -$135.00K.
| Period end | Fair Value, Liabilities Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 3 month | Fair Value, Liabilities Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 6 month | Fair Value, Liabilities Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 9 month | Fair Value, Liabilities Measured on Recurring Basis, Gain (Loss) Included in Other Income (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $0.00 derived: sum of 2 quarters · filed 2013-03-12 | $0.00 derived: sum of 3 quarters · filed 2013-03-12 | $0.00 10-K · filed 2013-03-12 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | $0.00 10-Q · filed 2012-11-09 | $0.00 derived: sum of 4 quarters · filed 2013-03-12 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-03-12 | $0.00 derived: sum of 4 quarters · filed 2013-03-12 |
| 2012-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2013-03-12 | $0.00 derived: sum of 2 quarters · filed 2013-03-12 | $0.00 derived: sum of 3 quarters · filed 2013-03-12 | $0.00 derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $0.00 derived: sum of 2 quarters · filed 2013-03-12 | $0.00 derived: sum of 3 quarters · filed 2013-03-12 | -$1.48M 10-K · filed 2013-03-12 |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-09 | $0.00 derived: sum of 2 quarters · filed 2012-11-09 | -$1.48M 10-Q · filed 2012-11-09 | -$2.20M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $0.00 10-Q · filed 2012-08-14 | -$1.48M 10-Q · filed 2012-08-14 | -$2.20M derived: sum of 3 quarters · filed 2013-03-12 | -$2.20M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | -$1.48M 10-Q · filed 2012-05-15 | -$2.20M derived: sum of 2 quarters · filed 2013-03-12 | -$2.20M derived: sum of 3 quarters · filed 2013-03-12 | -$2.21M derived: sum of 4 quarters · filed 2013-03-12 |
| 2010-12-31 | -$717.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$717.00K derived: sum of 2 quarters · filed 2013-03-12 | -$722.00K derived: sum of 3 quarters · filed 2013-03-12 | -$445.00K 10-K · filed 2013-03-12 |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | -$5.00K derived: sum of 2 quarters · filed 2011-11-14 | $272.00K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | -$5.00K 10-Q · filed 2011-08-09 | $272.00K 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | -$135.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |